[1] |
LI X, ZHANG L, PU CM, et al. Liver transplantation in acute-on-chronic liver failure: Timing of transplantation and selection of patient population[J]. Front Med(Lausanne), 2022, 9: 1030336. DOI: 10.3389/fmed.2022.1030336.
|
[2] |
Hepatology Branch of Chinese Medical Association, Infectious Diseases Branch of Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B(version 2022)[J]. Chin J Infect Dis, 2023, 41( 1): 3- 28. DOI: 10.3760/cma.j.cn311365-20230220-00050.
中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2022年版)[J]. 中华传染病杂志, 2023, 41( 1): 3- 28. DOI: 10.3760/cma.j.cn311365-20230220-00050.
|
[3] |
LIU L, HAN T, CAI JJ, et al. Clinical characteristics and progression risk factors for hepatitis B-related acute-on-chronic liver failure in elderly patients[J]. Chin J Geriatr, 2022, 41( 1): 51- 56. DOI: 10.3760/cma.j.issn.0254-9026.2022.01.011.
刘磊, 韩涛, 蔡均均, 等. 老年乙肝相关慢加急性肝衰竭患者临床特点及进展危险因素分析[J]. 中华老年医学杂志, 2022, 41( 1): 51- 56. DOI: 10.3760/cma.j.issn.0254-9026.2022.01.011.
|
[4] |
WANG X, ZHAO M, ZHANG C, et al. Establishment and clinical application of the nomogram related to risk or prognosis of hepatocellular carcinoma: A review[J]. J Hepatocell Carcinoma, 2023, 10: 1389- 1398. DOI: 10.2147/jhc.s417123.
|
[5] |
ZHANG LJ, TANG L, CHEN SY, et al. A nomogram for predicting the 4-year risk of chronic kidney disease among Chinese elderly adults[J]. Int Urol Nephrol, 2023, 55( 6): 1609- 1617. DOI: 10.1007/s11255-023-03470-y.
|
[6] |
CAI ZM, LIN HM, LI ZX, et al. A prediction nomogram for postoperative gastroparesis syndrome in right colon cancer: A retrospective study[J]. Langenbecks Arch Surg, 2023, 408( 1): 148. DOI: 10.1007/s00423-023-02885-6.
|
[7] |
Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
|
[8] |
ZHAO RH, SHI Y, ZHAO H, et al. Acute-on-chronic liver failure in chronic hepatitis B: An update[J]. Expert Rev Gastroenterol Hepatol, 2018, 12( 4): 341- 350. DOI: 10.1080/17474124.2018.1426459.
|
[9] |
KAKISAKA K, KATAOKA K, ONODERA M, et al. Alpha-fetoprotein: A biomarker for the recruitment of progenitor cells in the liver in patients with acute liver injury or failure[J]. Hepatol Res, 2015, 45( 10): E12- E20. DOI: 10.1111/hepr.12448.
|
[10] |
WANG XP, SHEN CF, YANG JJ, et al. Alpha-fetoprotein as a predictive marker for patients with hepatitis B-related acute-on-chronic liver failure[J]. Can J Gastroenterol Hepatol, 2018, 2018: 1232785. DOI: 10.1155/2018/1232785.
|
[11] |
QIN S, TANG SH, WANG XH, et al. Value of serum alpha-fetoprotein for the prognostic evaluation of hepatitis B virus-related acute-on-chronic liver failure treated with artificial liver[J]. Chin J Hepatol, 2020, 28( 1): 69- 72. DOI: 10.3760/cma.j.issn.1007-3418.2020.01.016.
秦森, 汤善宏, 王显红, 等. 血清甲胎蛋白在人工肝治疗乙型肝炎相关慢加急性肝衰竭预后评估中的价值[J]. 中华肝脏病杂志, 2020, 28( 1): 69- 72. DOI: 10.3760/cma.j.issn.1007-3418.2020.01.016.
|
[12] |
HOARE M, DAS T, Ageing ALEXANDER G., telomeres, senescence, and injury liver[J]. J Hepatol, 2010, 53( 5): 950- 961. DOI: 10.1016/j.jhep.2010.06.009.
|
[13] |
TANG CL, CHEN H, JIANG L, et al. Liver regeneration: Changes in oxidative stress, immune system, cytokines, and epigenetic modifications associated with aging[J]. Oxid Med Cell Longev, 2022, 2022: 9018811. DOI: 10.1155/2022/9018811.
|
[14] |
ALLAIRE M, GILGENKRANTZ H. The aged liver: Beyond cellular senescence[J]. Clin Res Hepatol Gastroenterol, 2020, 44( 1): 6- 11. DOI: 10.1016/j.clinre.2019.07.011.
|
[15] |
KAMATH PS, WIESNER RH, MALINCHOC M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33( 2): 464- 470. DOI: 10.1053/jhep.2001.22172.
|
[16] |
LI JQ, LIANG X, YOU SL, et al. Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure[J]. J Hepatol, 2021, 75( 5): 1104- 1115. DOI: 10.1016/j.jhep.2021.05.026.
|
[17] |
MITCHELL O, FELDMAN DM, DIAKOW M, et al. The pathophysiology of thrombocytopenia in chronic liver disease[J]. Hepat Med, 2016, 8: 39- 50. DOI: 10.2147/HMER.S74612.
|
[18] |
XU XW, HOU ZH, XU YY, et al. The dynamic of platelet count as a novel and valuable predictor for 90-day survival of hepatitis B virus-related acute-on-chronic liver failure patients[J]. Clin Res Hepatol Gastroenterol, 2021, 45( 2): 101482. DOI: 10.1016/j.clinre.2020.06.008.
|
[19] |
TU Y, LI X, CHEN MJ, et al. Value of platelet count and related scoring models in predicting the prognosis of hepatitis B virus-related acute-on-chronic liver failure[J]. J Clin Hepatol, 2023, 39( 6): 1308- 1312. DOI: 10.3969/j.issn.1001-5256.2023.06.009.
涂颖, 李雪, 陈美娟, 等. 血小板计数及相关评分模型对HBV相关慢加急性肝衰竭预后的预测价值[J]. 临床肝胆病杂志, 2023, 39( 6): 1308- 1312. DOI: 10.3969/j.issn.1001-5256.2023.06.009.
|
[20] |
ZACCHERINI G, WEISS E, MOREAU R. Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment[J]. JHEP Rep, 2021, 3( 1): 100176. DOI: 10.1016/j.jhepr.2020.100176.
|
[21] |
JALAN R, SALIBA F, PAVESI M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure[J]. J Hepatol, 2014, 61( 5): 1038- 1047. DOI: 10.1016/j.jhep.2014.06.012.
|
[22] |
TRIANTAFYLLOU E, WOOLLARD KJ, MCPHAIL MJW, et al. The role of monocytes and macrophages in acute and acute-on-chronic liver failure[J]. Front Immunol, 2018, 9: 2948. DOI: 10.3389/fimmu.2018.02948.
|